Search - tctmd.com

Displaying 41 - 60 of 3165

Sort: Relevancy | Date

Presentation TCT 2025

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Presenter: Shamir R. Mehta

October 28, 2025

Presentation TCT 2025

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

Presenter: Ruben W. de Winter

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Presenter: Evald H. Christiansen

October 27, 2025

Presentation TCT 2025

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Presenter: Lei Song

October 27, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

Presenter: Robert A. Lookstein

October 26, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

Presenter: Matthias Bossard

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Presenter: Suzanne J. Baron

October 26, 2025

News Conference News TCT 2025

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

Caitlin E. Cox

October 25, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

Todd Neale

October 16, 2025

Advertisement

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content